From December 2012 to March 2014, three randomized trials, each implementing a unique
intervention in primary care settings (repeated mailing, an electronic health record best …

This policy brief, one of two on the updated HCV guidelines, focuses on the new
recommendations on simplified service delivery for a public health approach to HCV testing …

Objectives. Between April and September of 2009 we evaluated the accuracy of the
OraQuick HCV rapid antibody test and assessed its feasibility for use by community-based …

BACKGROUND: An estimated 250,000 Canadians are infected with the hepatitis C virus
(HCV). The present study describes a cohort of individuals with HCV referred to community …

Abstract Background Direct Acting Antiviral (DAAs) drugs have a much lower burden of
treatment and monitoring requirements than regimens containing interferon and ribavirin …

Abstract Project Extension for Community Healthcare Outcomes (Project ECHOTM) is an
innovative telemedicine program that improves patient care by developing and supporting …

Although oral direct‐acting agent (DAA) therapies have the potential to reduce the burden of
hepatitis C virus (HCV) infection, treatment uptake remains low, particularly among people …

Background Point-of-care hepatitis C virus (HCV) RNA testing can facilitate single-visit
diagnosis and treatment. This study evaluated a single-visit test and treat intervention …

AIM: To determine rates of hepatitis C (HCV) risk factor ascertainment, testing, and referral in
urban primary care practices, with particular attention to the effect of race and ethnicity …

Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption
despite guidelines, particularly among racial/ethnic minorities and socioeconomically …